Trials / Unknown
UnknownNCT04479865
Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults
An Open-label, Randomized, Cross-over, Multiple Dose, Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of DA-5207 Transdermal Delivery System in Healthy Adults
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics of DA-5207 transdermal delivery system in healthy adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aricept 5mg Tablet | 1 tablet once daily |
| DRUG | Aricept 10mg Tablet | 1 tablet once daily |
| DRUG | DA-5207 150mg | 1 patch once weekly |
| DRUG | DA-5207 170mg | 1 patch once weekly |
Timeline
- Start date
- 2020-07-28
- Primary completion
- 2020-12-09
- Completion
- 2021-04-30
- First posted
- 2020-07-21
- Last updated
- 2021-04-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04479865. Inclusion in this directory is not an endorsement.